Then, a clinical study has been performed describing increased binding of [18F]PM-PBB3 in dementia patients, reflecting cortical-dominant AD and subcortical-dominant progressive supranuclear palsy (PSP) Tau topologies. Here, MAPT is linked to Alzheimer disease.